Follow
Nan van Geloven
Nan van Geloven
Assistant professor biostatistics, Leiden University medical center
Verified email at lumc.nl
Title
Cited by
Cited by
Year
Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
K Boonstra, RK Weersma, KJ van Erpecum, EA Rauws, BWM Spanier, ...
Hepatology 58 (6), 2045-2055, 2013
6722013
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ...
The Lancet Neurology 17 (1), 35-46, 2018
2772018
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4‐associated cholangitis from primary sclerosing cholangitis
K Boonstra, EL Culver, LM de Buy Wenniger, MJ van Heerde, ...
Hepatology 59 (5), 1954-1963, 2014
1922014
Oil-based or water-based contrast for hysterosalpingography in infertile women
K Dreyer, J Van Rijswijk, V Mijatovic, M Goddijn, HR Verhoeve, ...
New England Journal of Medicine 376 (21), 2043-2052, 2017
1832017
Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data
SM Zinkstok, MDI Vergouwen, ST Engelter, PA Lyrer, LH Bonati, M Arnold, ...
Stroke 42 (9), 2515-2520, 2011
1812011
Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: Disease penetrance and expression in cardiac ryanodine receptor mutation–carrying relatives
C van der Werf, I Nederend, N Hofman, N van Geloven, C Ebink, ...
Circulation: Arrhythmia and Electrophysiology 5 (4), 748-756, 2012
1792012
Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in Brugada syndrome: a study of electrocardiograms …
PG Postema, PFHM van Dessel, JA Kors, AC Linnenbank, G van Herpen, ...
Journal of the American College of Cardiology 55 (8), 789-797, 2010
1752010
Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a …
MAM Beijk, M Klomp, NJW Verouden, N van Geloven, KT Koch, ...
European heart journal 31 (9), 1055-1064, 2010
1482010
Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment …
P Damman, MAM Beijk, WJ Kuijt, NJW Verouden, N van Geloven, ...
Journal of the American College of Cardiology 57 (1), 29-36, 2011
1302011
The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI …
WJ Kikkert, N van Geloven, MH van der Laan, MM Vis, J Baan, KT Koch, ...
Journal of the American College of Cardiology 63 (18), 1866-1875, 2014
1232014
Neurocognitive deficits in children with sickle cell disease: a comprehensive profile
CT Hijmans, K Fijnvandraat, MA Grootenhuis, N van Geloven, H Heijboer, ...
Pediatric blood & cancer 56 (5), 783-788, 2011
1232011
Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi
T Israëls, MD van de Wetering, P Hesseling, N van Geloven, HN Caron, ...
Pediatric blood & cancer 53 (1), 47-52, 2009
1232009
Are patient characteristics associated with the accuracy of hysterosalpingography in diagnosing tubal pathology? An individual patient data meta-analysis
KA Broeze, BC Opmeer, N Van Geloven, S Coppus, JA Collins, ...
Human reproduction update 17 (3), 293-300, 2011
1152011
Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease
B Post, D Muslimovic, N van Geloven, JD Speelman, B Schmand, ...
Movement Disorders 26 (3), 449-456, 2011
1052011
Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD
DC Velseboer, M Broeders, B Post, N van Geloven, JD Speelman, ...
Neurology 80 (7), 627-633, 2013
1032013
Prediction meets causal inference: the role of treatment in clinical prediction models
N van Geloven, SA Swanson, CL Ramspek, K Luijken, M van Diepen, ...
European journal of epidemiology 35, 619-630, 2020
852020
Aspirin in Alzheimer’s disease: increased risk of intracerebral hemorrhage: cause for concern?
H Thoonsen, E Richard, P Bentham, R Gray, N van Geloven, RJ De Haan, ...
Stroke 41 (11), 2690-2692, 2010
822010
Physiological-based cord clamping in very preterm infants—Randomised controlled trial on effectiveness of stabilisation
R Knol, E Brouwer, T van den Akker, P DeKoninck, N van Geloven, ...
Resuscitation 147, 26-33, 2020
752020
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial
PF van der Meer, PF Ypma, N van Geloven, JA van Hilten, ...
Blood, The Journal of the American Society of Hematology 132 (2), 223-231, 2018
702018
Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice–the ECSTATIC study: a cluster randomised non …
CH Luymes, RKE Poortvliet, N van Geloven, MWM de Waal, YM Drewes, ...
BMC medicine 16, 1-14, 2018
692018
The system can't perform the operation now. Try again later.
Articles 1–20